APCOM welcomes the news of the HPTN 083 trail that evaluate the safety and efficacy of the injectable drug cabotegravir (CAB LA), for PrEP in HIV-uninfected cisgender men and transgender women who have sex with men, including two countries in Asia, Thailand and Vietnam.
APCOM has a PrEP website that aims to improve awareness, through a resource database, and to advocate for and build demand in our communities for the right to access proven and comprehensive prevention approaches. It is the work of contributions from community activists, civil society organisations and policy advocates to co-create an educational and advocacy platform.
More information on HPTN 083
UNAIDS welcomes new tool for HIV prevention for gay men and other men who have sex with men and transgender women
More information on PrEP in Asia:
PrEP in Indonesia:
PrEP in the Philippines:
PrEP in Thailand:
PrEP in Vietnam:
Vietnam announces rollout of PrEP